Advertisement

Index by author

January 01, 1989; Volume 35,Issue 1

A

  1. Anderson, D

    1. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;

B

  1. Balfour, C

    1. Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;

  2. Beer, B

    1. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;

  3. Beyer, C F

    1. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;

  4. Blume, A J

    1. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;

  5. Burstein, S H

    1. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;

C

  1. Cheung, A H

    1. Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;

  2. Correia, M A

    1. Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;

  3. Cox, R F

    1. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
      R F Cox and B L Waszczak
      Molecular Pharmacology January 1989, 35 (1) 125-131;

  4. Criscione, K R

    1. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;

  5. Czajkowski, C

    1. Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;

D

  1. Dawson, G

    1. Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;

  2. Dixon, R A

    1. Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;

F

  1. Farb, D H

    1. Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;

  2. Fine, J S

    1. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;

  3. Fischer, P H

    1. Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;

  4. Ford, J M

    1. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;

  5. Francel, P C

    1. Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;

G

  1. Gasiewicz, T A

    1. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;

  2. Gibbs, T T

    1. Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;

  3. Girard, P R

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

  4. Gistrak, M A

    1. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

  5. Gnegy, M E

    1. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
      P H Roseboom and M E Gnegy
      Molecular Pharmacology January 1989, 35 (1) 139-147;

  6. Grunewald, G L

    1. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;

H

  1. Hahn, E F

    1. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

  2. Hait, W N

    1. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;

  3. Halpert, J

    1. Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;

  4. Hirsch, J D

    1. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;

  5. Hoffman, B B

    1. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
      J M Thomas and B B Hoffman
      Molecular Pharmacology January 1989, 35 (1) 116-124;

  6. Hsu, A H

    1. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;

  7. Hull, K

    1. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;

  8. Hunter, S A

    1. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;

  9. Hwang, S B

    1. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;

I

  1. Itzhak, Y

    1. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

J

  1. Jaw, J Y

    1. Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;

K

  1. Karlsson, M O

    1. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
      M O Karlsson and A Neil
      Molecular Pharmacology January 1989, 35 (1) 59-66;

  2. Keefer, J F

    1. Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;

  3. Klein, M

    1. Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;

  4. Kunugi, K

    1. Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;

  5. Kuo, J F

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

L

  1. Lam, M H

    1. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;

  2. Loullis, C C

    1. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;

  3. Lunetta, J M

    1. Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;

M

  1. Malkowitz, L

    1. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;

  2. McKinney, M

    1. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;

  3. Musacchio, J M

    1. Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;

N

  1. Neil, A

    1. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
      M O Karlsson and A Neil
      Molecular Pharmacology January 1989, 35 (1) 59-66;

  2. Ng, D S

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

P

  1. Parente, J E

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

  2. Pasternak, G W

    1. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

  3. Paturzo, J J

    1. Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;

  4. Price, M

    1. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

  5. Prozialeck, W C

    1. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;

R

  1. Roseboom, P H

    1. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
      P H Roseboom and M E Gnegy
      Molecular Pharmacology January 1989, 35 (1) 139-147;

S

  1. Sall, D J

    1. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;

  2. Shilstone, J

    1. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;

  3. Sigal, I S

    1. Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;

  4. Silverstone, A E

    1. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;

  5. Strader, C D

    1. Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;

  6. Sugiyama, K

    1. Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;

T

  1. Thomas, J M

    1. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
      J M Thomas and B B Hoffman
      Molecular Pharmacology January 1989, 35 (1) 116-124;

V

  1. Vazquez-Padua, M A

    1. Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;

  2. Vella-Rountree, L

    1. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;

W

  1. Walsh, M P

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

  2. Waszczak, B L

    1. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
      R F Cox and B L Waszczak
      Molecular Pharmacology January 1989, 35 (1) 125-131;

  3. Wise, B

    1. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;

  4. Wong, K

    1. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

  5. Wu, C S

    1. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
      C S Wu and J T Yang
      Molecular Pharmacology January 1989, 35 (1) 85-92;

Y

  1. Yang, J T

    1. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
      C S Wu and J T Yang
      Molecular Pharmacology January 1989, 35 (1) 85-92;

  2. Ye, Q

    1. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;
Back to top

In this issue

Advertisement